510(k) Report

510(k) · Cleared

Cleared

Zyno Medical Administration Set

K120685510(k) AbbreviatedCleared Sep 7, 2012185-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Zyno Medical, LLC · FPA Set, Administration, Intravascular

Cleared on Sep 7, 2012 as substantially equivalent to K981792 (Baxter Healthcare Corp, 1998) and 2 other predicates after a 185-day review. Its family tree reaches back 2 generations to 1983. 2 of the 17 devices in its family, counting itself, have a Class I recall. 12 later devices descend from it.

Decided
Sep 7, 2012
Review
185 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K832284 (1983). 4 ancestors in all. 12 later devices descend from it, 6 citing it directly. 2 of the 17 devices in this family, counting this one, have a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 2006: 1 other ancestor1997: 1 other ancestor2024: 2 descendants cleared2016: 1 descendant cleared, 1 with a Class I recall12015: 1 descendant cleared2014: 2 descendants cleared, 1 with a Class I recall12026: 1 descendant cleared2020: 1 descendant cleared2023: 1 descendant cleared2018: 1 descendant cleared2022: 1 descendant cleared2025: 1 descendant clearedK832284 · Solution Admin. Set 2C9096 W/10 PVC · Travenol Laboratories, S.A. · 1983 · recalledK981792 · Solution Administration Set · Baxter Healthcare Corp · 1998 · recalled19801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 6 descendants, 2 with a Class I recall22 generations forward: 4 descendants3 generations forward: 2 descendants K981792 · Solution Administration Set · Baxter Healthcare Corp · 1998 · recalledK832284 · Solution Admin. Set 2C9096 W/10 PVC · Travenol Laboratories, S.A. · 1983 · recalled0
  1. Root · 2 generations backK832284 Solution Admin. Set 2C9096 W/10 PVCTravenol Laboratories, S.A. · 1983 · Recalled
  2. 1 generation backK981792 Solution Administration SetBaxter Healthcare Corp · 1998 · Recalled
  3. This deviceK120685 Zyno Medical Administration SetZyno Medical, LLC · 2012
  4. Descendant · cites it directly · 5 of its ownK151151 U & U Intravascular Administration SetU&U Medical Technology Co, Ltd. · 2015
  5. Descendant · cites it directly · 1 of its ownK232316 DEKA Infusion System, DEKA Administration SetDeka Research and Development · 2024
  6. Descendant · 2 generations on · 1 of its ownK230343 ProSeal™ Closed System Administration SetEpic Medical Pte., Ltd. · 2023
  7. Descendant · 2 generations on · 1 of its ownK173361 IV Administration SetB.Braun Medical, Inc. · 2018
  8. Descendant · cites it directly · 1 of its ownK140783 Halo Ambulatory Infusion SystemZyno Medical, LLC · 2014 · Recalled (Class I)

Showing 5 of 12 descendants. See all descendants

Descendants cleared per year

2014: 22015: 12016: 12018: 12020: 12022: 12023: 12024: 22025: 12026: 1
2014high 2 (2014) · low 0 (2017)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 12 · See all
  • K151151U & U Intravascular Administration SetU&U Medical Technology Co, Ltd. · 2015 · cites it directly5descendants
  • K232316DEKA Infusion System, DEKA Administration SetDeka Research and Development · 2024 · cites it directly1descendant
  • K230343ProSeal™ Closed System Administration SetEpic Medical Pte., Ltd. · 2023 · 2 generations on1descendant
  • K173361IV Administration SetB.Braun Medical, Inc. · 2018 · 2 generations on1descendant
  • K140783Halo Ambulatory Infusion SystemZyno Medical, LLC · 2014 · cites it directly1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K832284Solution Admin. Set 2C9096 W/10 PVCTravenol Laboratories, S.A.19832
−1K981792Solution Administration SetBaxter Healthcare Corp19985
0 (this device)K120685Zyno Medical Administration SetZyno Medical, LLC2012—
+1K151151U & U Intravascular Administration SetU&U Medical Technology Co, Ltd.2015—
+1K232316DEKA Infusion System, DEKA Administration SetDeka Research and Development2024—
+2K230343ProSeal™ Closed System Administration SetEpic Medical Pte., Ltd.2023—
+2K173361IV Administration SetB.Braun Medical, Inc.2018—
+1K140783Halo Ambulatory Infusion SystemZyno Medical, LLC2014Class I

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201421
201510
201611
201810
202010
202210
202310
202420
202510
202610
FIG. 1 — Lineage of K120685, 1983–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981792Solution Administration Set
Summary page 1
…Zyno Medical's Administration Set issubstantially equivalent to the following predicate devices: --Solution Administration Set, Baxter H-ealthcare Corporation (K981792) --AMSURE I.V. Administration Set, Amsino International, Inc (K973107) A-V Administration Set, Health Line Intern…
Baxter Healthcare Corp19985
*K973107Amsino I.V. Administration Set
Summary page 1
…predicate devices: --Solution Administration Set, Baxter H-ealthcare Corporation (K981792) --AMSURE I.V. Administration Set, Amsino International, Inc (K973107) A-V Administration Set, Health Line International Corporation (K060352) Page 1 of 3 5. STATEMENT…
Amsino Intl., Inc.1997—
*K060352Health Line International Corporations,S IV Administrative Sets
Summary page 1
…orporation (K981792) --AMSURE I.V. Administration Set, Amsino International, Inc (K973107) A-V Administration Set, Health Line International Corporation (K060352) Page 1 of 3 5. STATEMENT OF INTENDED USE: The Zyno Medical Administration Set isadevice used to a…
Health Line International Corporation2006—

Also cleared against K981792: 1 other device →

What descends from it? (12)

See all 12

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K151151U & U Intravascular Administration SetU&U Medical Technology Co, Ltd.20155
K232316DEKA Infusion System, DEKA Administration SetDeka Research and Development20241
K140783Halo Ambulatory Infusion System Class IZyno Medical, LLC20141
K252543AMSafe Administration Set (BA-70075, BA-70071-D, BA-70070, BA-70071-P, BA-70072…Amsino International, Inc.20260
K153193Halo II Ambulatory Infusion System (also with trade names Nimbus II Ambulatory Infusion… Class IZyno Medical, LLC20160
K132841Zyno Medical Administration SetZyno Medical, LLC20140

Has anything in its family been recalled? (2 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K153193Halo II Ambulatory Infusion System (also with trade names Nimbus II Ambulatory Infusion System, EVAA…Zyno Medical, LLC · 2016 · Cites it directly · ◆ in the 2016 descendants bar of FIG. 13 Class I recalls
  • K140783Halo Ambulatory Infusion SystemZyno Medical, LLC · 2014 · Cites it directly · ◆ in the 2014 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 29 years and passes through 3 companies; a new generation was cleared every 14.6 years on median.
  • 2 of the 4 ancestors have a recall of any class.
  • Of its descendants, K151151 (U&U Medical Technology Co, Ltd., 2015) has gone furthest, with 5 descendants of its own.
  • 1 other device also cites its predicate K981792.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The Zyno Medical Administration Set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120685: Zyno Medical Administration Set.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K120685

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026